- February, 2021: The Vision of TearClear’s Future with CEO Robert Dempsey
- December, 2020: TearClear Completes Pre-IND FDA Meeting for Preservative Free Multi-Dose Delivery of Latanoprost
- October, 2020: Glaucoma & ocular surface preservation: Key factors for ODs to consider (Optometry Times)
- October, 2020: The scourge of preserved eye drops (Ocular Surgery News)
- June, 2020: Dry Eye Therapies on the Horizon (Opthalmology Management)
- April 15, 2020: Early-Stage Company Aims to Disrupt Global Ophthalmologic Drugs Market (eyewire News)
- November 25, 2019: Wet cheekbones: Is it time to move away from eye drops? (Healio Ocular Surgery News)
- November 12, 2019: We’ve got your BAK (OIS)
Preservative-free ophthalmic drug delivery